1. Home
  2. AIMD vs ULY Comparison

AIMD vs ULY Comparison

Compare AIMD & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • ULY
  • Stock Information
  • Founded
  • AIMD 1984
  • ULY 2013
  • Country
  • AIMD United States
  • ULY United States
  • Employees
  • AIMD N/A
  • ULY N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • AIMD Health Care
  • ULY
  • Exchange
  • AIMD Nasdaq
  • ULY Nasdaq
  • Market Cap
  • AIMD 8.5M
  • ULY 6.7M
  • IPO Year
  • AIMD N/A
  • ULY N/A
  • Fundamental
  • Price
  • AIMD $0.59
  • ULY $0.50
  • Analyst Decision
  • AIMD
  • ULY Strong Buy
  • Analyst Count
  • AIMD 0
  • ULY 1
  • Target Price
  • AIMD N/A
  • ULY $1.50
  • AVG Volume (30 Days)
  • AIMD 1.3M
  • ULY 82.0K
  • Earning Date
  • AIMD 03-07-2025
  • ULY 03-13-2025
  • Dividend Yield
  • AIMD N/A
  • ULY N/A
  • EPS Growth
  • AIMD N/A
  • ULY N/A
  • EPS
  • AIMD N/A
  • ULY 7.18
  • Revenue
  • AIMD $40,633.00
  • ULY $155,926,000.00
  • Revenue This Year
  • AIMD N/A
  • ULY N/A
  • Revenue Next Year
  • AIMD N/A
  • ULY $4.29
  • P/E Ratio
  • AIMD N/A
  • ULY $0.07
  • Revenue Growth
  • AIMD N/A
  • ULY N/A
  • 52 Week Low
  • AIMD $0.40
  • ULY $0.41
  • 52 Week High
  • AIMD $3.10
  • ULY $3.45
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 46.09
  • ULY 49.65
  • Support Level
  • AIMD $0.57
  • ULY $0.50
  • Resistance Level
  • AIMD $0.64
  • ULY $0.55
  • Average True Range (ATR)
  • AIMD 0.09
  • ULY 0.04
  • MACD
  • AIMD -0.02
  • ULY 0.01
  • Stochastic Oscillator
  • AIMD 10.62
  • ULY 62.31

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: